Loading...
Rituximab Administration in Third Trimester of Pregnancy Suppresses Neonatal B-Cell Development
We describe the effect on the neonate of administration of rituximab to a woman with idiopathic thrombocytopenic purpura (ITP). Rituximab, an anti-CD20 antibody, was given weekly for 4 weeks to a woman with ITP in her third trimester of pregnancy. One month after the last rituximab administration a...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi Publishing Corporation
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2438602/ https://ncbi.nlm.nih.gov/pubmed/18596903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2008/271363 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|